Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-03 · 398 (3) · 2933-2944
DOI: 10.1007/s00210-024-03456-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 21.09.2024. Verfasst von Jia Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: The College of Life Sciences, Northwest University, No. 229 Taibai North Road, Xi'an City, 710069, Shaanxi Province, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Osteogenesis, Spondylitis, Ankylosing, Smad Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The College of Life Sciences, Northwest University, No. 229 Taibai North Road, Xi'an City, 710069, Shaanxi Province, China.
- Department of Rheumatology and Immunology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), No. 569 Xinsi Road, Baqiao District, Xi'an City, 710038, Shaanxi Province, China.
- Department of Rheumatology Immunology and Endocrinology, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, Beilin District, Xi'an City, 710061, Shaanxi Province, China.
- Department of Rheumatology and Immunology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), No. 569 Xinsi Road, Baqiao District, Xi'an City, 710038, Shaanxi Province, China. 1372063594…
Zitieren
APA
Chen, J., Yang, X., Huang, Y., Cao, X., Wu, Z., & Feng, Y. (2025). Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(3), 2933-2944. https://doi.org/10.1007/s00210-024-03456-2
Vancouver
Chen J, Yang X, Huang Y, Cao X, Wu Z, Feng Y. Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(3):2933-2944. doi:10.1007/s00210-024-03456-2
BibTeX
@article{Chen2025,
author = {Chen, Jia and Yang, Xichao and Huang, Yumin and Cao, Xue and Wu, Zhenbiao and Feng, Yuan},
title = {Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {3},
pages = {2933--2944},
doi = {10.1007/s00210-024-03456-2}
}
EUVIMED